Form 4: Kellogg Foundation Trust Sells K Shares

The W.K. Kellogg Foundation Trust sold 114,583 shares of Kellanova common stock for approximately $9.17 million, reducing its beneficial ownership to 45,326,620 shares.

Summary

• The W.K. Kellogg Foundation Trust, a 10% owner and director of Kellanova (K), sold 114,583 shares of common stock.
• The transaction occurred on August 14, 2025, with a deemed execution date on the same day.
• The shares were sold at a price of $80.0734 per share, totaling approximately $9,175,000 in proceeds.
• Following this transaction, the W.K. Kellogg Foundation Trust beneficially owns 45,326,620 shares of Kellanova.
• The sale was conducted pursuant to a Rule 10b5-1 trading plan, with instructions given on May 7, 2024.

Sentiment

Score: 5

Explanation: The filing reports a scheduled sale of shares by a significant shareholder (W.K. Kellogg Foundation Trust) under a Rule 10b5-1 plan. While insider selling can sometimes be perceived negatively, the pre-arranged nature of the sale suggests it is not a reaction to new adverse information, making the sentiment neutral.

Positives

• The sale was executed at a specific price of $80.0734 per share.
• The transaction was conducted under a pre-arranged Rule 10b5-1 trading plan, indicating a scheduled sale rather than a reaction to immediate market conditions or new adverse information.

Negatives

• A significant shareholder, the W.K. Kellogg Foundation Trust, reduced its stake in Kellanova by selling 114,583 shares.

Future Outlook

NA

Industry Context

NA

Related Party Transactions

• Sale of common stock by the W.K. Kellogg Foundation Trust, which is identified as a 10% owner and has a director relationship with Kellanova.

Stakeholder Impact

• Shareholders: The sale by a significant shareholder could be perceived as a minor reduction in insider confidence, though mitigated by the pre-arranged nature of the 10b5-1 plan.

Key Dates

Recommendation

The filing details a pre-scheduled sale by a significant shareholder under a Rule 10b5-1 plan. This type of transaction is generally not indicative of new fundamental information about the company's performance or outlook, but rather a planned liquidity event for the selling entity. Therefore, it does not provide a basis for a change in investment recommendation.

Keywords

Kellanova, K, W.K. Kellogg Foundation Trust, insider trading, stock sale, Form 4, beneficial ownership, 10b5-1 plan